These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 29737092)
1. [Study of Kinase Inhibitor WP1066 on the STAT3/JAK2 of Prostate Stromal Cells]. Li YX; Li JM; Wei Q; Zhang ZP; Wu J; Wang AG Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):65-68. PubMed ID: 29737092 [TBL] [Abstract][Full Text] [Related]
2. STAT3 inhibitor WP1066 as a novel therapeutic agent for bCCI neuropathic pain rats. Xue ZJ; Shen L; Wang ZY; Hui SY; Huang YG; Ma C Brain Res; 2014 Oct; 1583():79-88. PubMed ID: 25084036 [TBL] [Abstract][Full Text] [Related]
3. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells. Ferrajoli A; Faderl S; Van Q; Koch P; Harris D; Liu Z; Hazan-Halevy I; Wang Y; Kantarjian HM; Priebe W; Estrov Z Cancer Res; 2007 Dec; 67(23):11291-9. PubMed ID: 18056455 [TBL] [Abstract][Full Text] [Related]
4. The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6. Lu K; Fang XS; Feng LL; Jiang YJ; Zhou XX; Liu X; Li PP; Chen N; Ding M; Wang N; Zhang J; Wang X Cancer Lett; 2015 Apr; 359(2):250-8. PubMed ID: 25636517 [TBL] [Abstract][Full Text] [Related]
5. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells. Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II activates JAK2/STAT3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes. Kandalam U; Clark MA Regul Pept; 2010 Jan; 159(1-3):110-6. PubMed ID: 19748527 [TBL] [Abstract][Full Text] [Related]
7. WP1066 suppresses macrophage cell death induced by inflammasome agonists independently of its inhibitory effect on STAT3. Honda S; Sadatomi D; Yamamura Y; Nakashioya K; Tanimura S; Takeda K Cancer Sci; 2017 Mar; 108(3):520-527. PubMed ID: 28035720 [TBL] [Abstract][Full Text] [Related]
8. Experimental abdominal aortic aneurysm growth is inhibited by blocking the JAK2/STAT3 pathway. Xiao J; Wei Z; Chen X; Chen W; Zhang H; Yang C; Shang Y; Liu J Int J Cardiol; 2020 Aug; 312():100-106. PubMed ID: 32334849 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo. Judd LM; Menheniott TR; Ling H; Jackson CB; Howlett M; Kalantzis A; Priebe W; Giraud AS PLoS One; 2014; 9(5):e95993. PubMed ID: 24804649 [TBL] [Abstract][Full Text] [Related]
10. TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway. Hou J; Lv A; Deng Q; Zhang G; Hu X; Cui H Oncol Rep; 2019 Feb; 41(2):753-764. PubMed ID: 30431125 [TBL] [Abstract][Full Text] [Related]
11. JAK2 tyrosine kinase inhibitor AG490 suppresses cell growth and invasion of gallbladder cancer cells via inhibition of JAK2/STAT3 signaling. Fu LX; Lian QW; Pan JD; Xu ZL; Zhou TM; Ye B J Biol Regul Homeost Agents; 2017; 31(1):51-58. PubMed ID: 28337870 [TBL] [Abstract][Full Text] [Related]
12. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro. Tang YJ; Sun ZL; Wu WG; Xing J; He YF; Xin DM; Han P Genet Mol Res; 2015 Mar; 14(1):2450-60. PubMed ID: 25867391 [TBL] [Abstract][Full Text] [Related]
13. Role of a Janus kinase 2-dependent signaling pathway in platelet activation. Lu WJ; Lin KC; Huang SY; Thomas PA; Wu YH; Wu HC; Lin KH; Sheu JR Thromb Res; 2014 Jun; 133(6):1088-96. PubMed ID: 24731555 [TBL] [Abstract][Full Text] [Related]
14. Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway. Kim B; Kim HS; Kim S; Haegeman G; Tsang BK; Dhanasekaran DN; Song YS Cancer Res Treat; 2017 Apr; 49(2):338-349. PubMed ID: 27456942 [TBL] [Abstract][Full Text] [Related]
15. [(*)AG490 could suppress bone marrow mesenchymal stem cells migration, mineralization and bone defect healing via inhibiting Jak2-STAT3 pathway]. Yu X; Wan QL; Li Z; Li ZB Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 May; 53(5):293-300. PubMed ID: 29972985 [No Abstract] [Full Text] [Related]
16. Inhibition of JAK2/STAT3 signaling suppresses bone marrow stromal cells proliferation and osteogenic differentiation, and impairs bone defect healing. Yu X; Li Z; Wan Q; Cheng X; Zhang J; Pathak JL; Li Z Biol Chem; 2018 Oct; 399(11):1313-1323. PubMed ID: 30044759 [TBL] [Abstract][Full Text] [Related]
17. WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation. Verstovsek S; Manshouri T; Quintás-Cardama A; Harris D; Cortes J; Giles FJ; Kantarjian H; Priebe W; Estrov Z Clin Cancer Res; 2008 Feb; 14(3):788-96. PubMed ID: 18245540 [TBL] [Abstract][Full Text] [Related]
18. TGF-beta1 suppresses IL-6-induced STAT3 activation through regulation of Jak2 expression in prostate epithelial cells. Starsíchová A; Lincová E; Pernicová Z; Kozubík A; Soucek K Cell Signal; 2010 Nov; 22(11):1734-44. PubMed ID: 20603212 [TBL] [Abstract][Full Text] [Related]
19. Combination of MEK Inhibitor and the JAK2-STAT3 Pathway Inhibition for the Therapy of Colon Cancer. Jin J; Guo Q; Xie J; Jin D; Zhu Y Pathol Oncol Res; 2019 Apr; 25(2):769-775. PubMed ID: 30706361 [TBL] [Abstract][Full Text] [Related]
20. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Iwamaru A; Szymanski S; Iwado E; Aoki H; Yokoyama T; Fokt I; Hess K; Conrad C; Madden T; Sawaya R; Kondo S; Priebe W; Kondo Y Oncogene; 2007 Apr; 26(17):2435-44. PubMed ID: 17043651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]